Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 2051-2063

  Xu, Guang Ya ^a   Shi, Hua Shan ^a   Ren, Lai Bin ^a   Gou, Hong Feng ^a   Gong, Dao Yin ^a   Gao, Xiang ^a,b   Huang, Ning ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Cell apoptosis; Colon cancer; Nanoformulation; Quercetin

Indexed keywords

COPOLYMER; MONOMETHOXY POLY(ETHYLENE GLYCOL) POLY(EPSILON CAPROLACTONE); QUERCETIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BIOMATERIAL; DRUG CARRIER; MACROGOL DERIVATIVE; METHOXY POLY(ETHYLENE GLYCOL-CO-EPSILON-CAPROLACTONE); MICELLE; NANOPARTICLE; POLYESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOMA CELL; COLON CANCER; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG EFFICACY; DRUG HALF LIFE; DRUG STRUCTURE; ENCAPSULATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MAXIMUM PLASMA CONCENTRATION; MICELLE; MOUSE; NANOPHARMACEUTICS; NONHUMAN; PARTICLE SIZE; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; COLONIC NEOPLASMS; DRUG DELIVERY SYSTEM; DRUG EFFECTS; DRUG SCREENING; HUMAN; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PROCEDURES; SOLUBILITY; SPRAGUE DAWLEY RAT; TUMOR CELL LINE;

MUS;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BIOCOMPATIBLE MATERIALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICELLES; NANOPARTICLES; NEOVASCULARIZATION, PATHOLOGIC; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS; QUERCETIN; RATS, SPRAGUE-DAWLEY; SOLUBILITY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84928139633     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S75550     Document Type: Article

References (45)

1. Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366(8):687-696.
2. Rebecca S, Jiemin M, Zhaohui Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29.
3. Rebecca S, Carol DS, Ahmedin J. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64:104-117.
4. Turati F, Edefonti V, Bravi F, et al. Adherence to the European food safety authority's dietary recommendations and colorectal cancer risk. J Clin Nutr. 2012;66:517-522.
5. Key TJ, Appleby PN, Masset G, et al. Vitamins, minerals, essential fatty acids and colorectal cancer risk in the United Kingdom Dietary Cohort Consortium. J Cancer. 2012;131:320-325.
6. Boffetta P, Hazelton WD, Chen Y. Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine - a pooled analysis of over 500,000 subjects in the Asia Cohort Consortium. Ann Oncol. 2012;23:1894-1898.
7. Joshu CE, Parmigiani G, Colditz GA, Platz, EA. Opportunities for the primary prevention of colorectal cancer in the United States. Cancer Prev Res. 2012;5:138-145.
8. van Kruijsdijk RC, van der Graaf Y, Peeters PH, Visseren FL. Cancer risk in patients with manifest vascular disease: effects of smoking, obesity, and metabolic syndrome. Cancer Epidemiol Biomarkers Prev. 2013;22:1267-1277.
9. Saleh M, Trinchieri G. Innate immune mechanisms of colitis and colitis-associated colorectal cancer. Nat Rev Immunol. 2011;11:9-20.
10. Seshagiri S, Stawiski EW, Durinck S, et al. Recurrent R-spondin fusions in colon cancer. Nature. 2012;488:660-664.
11. Prahallad A, Sun C, Huang S, et al. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. Nature. 2012;483:100-103.
12. Qinjie W, Senyi D, Ling L, et al. Biodegradable polymeric micelle-encapsulated quercetin suppresses tumor growth and metastasis in both transgenic zebrafish and mouse models. Nanoscale. 2013;5:12480-12493.
13. Gupta SC, Kim JH, Prasad S, et al. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 2010;29(3):405-434.
14. Slusarz A, Shenouda NS, Sakla MS, et al. Common botanical compounds inhibit the Hedgehog signaling pathway in prostate cancer. Cancer Res. 2010;70:3382-3391.
15. Cheng S, Gao N, Zhang Z, et al. Quercetin induces tumor selective apoptosis through down regulation of Mcl-1 and activation of bax. Clin Cancer Res. 2010;16:5679-5692.
16. Sahoulia F, Drosopoulos K, Doubravska L, et al. Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol Cancer Ther. 2007;6:2591-2599.
17. Jones D, Lamb JH, Verschoyle RD, et al. Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclooxygenase activity. Br J Cancer. 2004;91:1213-1219.
18. Tottey S, Waldron KJ, Firbank SJ. Protein-folding location can regulate manganese-binding versus copper- or zinc-binding. Nature. 2008;455:1138-1142.
19. Voelkel JC. TRAIL-mediated signaling in prostate, bladder and renal cancer. Nat Rev Urol. 2011;8:417-427.
20. Coleman DT, Bigelow R, Cardelli JA. Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation. Mol Cancer Ther. 2009;8:214-224.
21. Xiang G, Bilan W, Xiawei W, et al. Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer. Nanoscale. 2012;4:7021-7030.
22. Xiang G, Fengjin Z, Gang G, et al. Improving the anti-colon cancer activity of curcumin with biodegradable nano-micelles. J Mater Chem B. 2013;1:5778-5790.
23. Wang BL, Gao X, Men K, et al. Treating acute cystitis with biodegradable micelle-encapsulated quercetin. Int J Nanomed. 2012;7:2239-2247.
24. Chen A, Xu J, Johnson AC. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene. 2006;25:278-287.
25. O'Sullivan-Coyne G, O'Sullivan GC, O'Donovan TR, et al. Curcumin induces apoptosis-independent death in oesophageal cancer cells. Br J Cancer. 2009;101:1585-1595.
26. Wei YQ, Zhao X, Kariya Y, et al. Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res. 1994;54:4952-4957.
27. Yuan ZP, Chen LJ, Fan LY, et al. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin Cancer Res. 2006;12:3193-3199.
28. Li X, Zhang Z, Li J, et al. Diclofenac/biodegradable polymer micelles for ocular applications. Nanoscale. 2012;4:4667-4673.
29. Parrott MC, DeSimone JM. Drug delivery: relieving PEGylation. Nat Chem. 2012;4:13-14.
30. Guo G, Fu SZ, Zhou LX, et al. Preparation of curcumin loaded poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) nanofibers and their in vitro antitumor activity against Glioma 9L cells. Nanoscale. 2011;3:3825-3832.
31. Srikanth M, Kessler JA. Nanotechnology-novel therapeutics for CNS disorders. Nat Rev Neurol. 2012;8:307-318.
32. Zubarev ER. Nanoparticle synthesis: any way you want it. Nat Nanotechnol. 2013;8:396-397.
33. Wang Q, Zhuang X, Mu J, et al. Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids. Nat Commun. 2013;4:1867.
34. Brinker CJ. Nanoparticle immunotherapy: Combo combat. Nat Mater. 2012;11:831-832.
35. Bee-Jen T, Yuanjie L and Kai-Lun C, et al. Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer. Int J Nanomed. 2012;7:651-661.
36. Gao X, Wang B, Wei X, et al. Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer. Nanoscale. 2012;4:7021-7030.
37. Cabral H, Matsumoto Y, Mizuno K, et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol. 2011;6:815-823.
38. MacKay JA, Chen M, McDaniel JR, et al. Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumours after a single injection. Nat Mater. 2009;8:993-999.
39. Gong C, Xie Y, Wu Q, et al. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma. Nanoscale. 2012;4:6004-6017.
40. Gong C, Wang C, Wang Y, et al. Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites. Nanoscale. 2012;4:3095-3104.
41. Gao X, Wang B, Wei X, et al. Preparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer. Int J Nanomed. 2013;8:971-982.
42. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 2001;47:113-131.
43. Gou ML, Men K, Shi HS, et al. Curcumin loaded biodegradable polymeric micelle for colon cancer therapy in vitro and in vivo. Nanoscale. 2011;3:1558-1567.
44. Gou M, Wei X, Men K, et al. PCL/PEG copolymeric nanoparticles: potential nanoplatforms for anticancer agent delivery. Curr Drug Targets. 2011;12:1131-1150.
45. Chakraborty S, Stalin S, Das N, et al. The use of nanoquercetin to arrest mitochondrial damage and MMP-9 up regulation during prevention of gastric inflammation induced by ethanol in rat. Biomaterials. 2012;33:2991-3001.